Abstract
Intraventricular hemorrhage (IVH) has been associated with poor prognosis in patients with spontaneous intracerebral hemorrhage. Several factors contribute to the deleterious effects of IVH, including direct mass effects of the ventricular blood clot on ependymal and subependymal brain structures, mechanical and inflammatory impairment of the Pacchioni granulations by blood and its breakdown products, and disturbance of physiological cerebrospinal fluid (CSF) circulation. Acute obstructive hydrocephalus represents a major life-threatening complication of IVH and is usually treated with an external ventricular drainage (EVD). However, treatment with EVD alone is frequently not sufficiently effective due to obstruction of the catheter by blood. In the past two decades, intraventricular fibrinolysis (IVF) has been increasingly used for maintenance of EVD functionality and acceleration of ventricular clot resolution in such patients. Unfortunately, there is no prospective, randomized controlled trial addressing the effect of IVF on clinical outcome. The available data on IVF consist of small retrospective case series, case reports, and a few prospective case–control studies, which are the subject of the present review article. All these studies, when considered in their entirety, suggest that IVF has a positive impact on mortality and functional outcome, and could be considered as a treatment option for selected patients.
Similar content being viewed by others
References
Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med. 1999;27:617–21.
Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl. 2006;96:65–8.
Steiner T, Diringer MN, Schneider D, et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery. 2006;59:767–73. (discussion 73–4).
Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373:1632–44.
Sjoblom L, Hardemark HG, Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke. 2001;32:2567–74.
Huttner HB, Kohrmann M, Berger C, Georgiadis D, Schwab S. Predictive factors for tracheostomy in neurocritical care patients with spontaneous supratentorial hemorrhage. Cerebrovasc Dis. 2006;21:159–65.
Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.
Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke. 1998;29:1352–7.
Shapiro SA, Campbell RL, Scully T. Hemorrhagic dilation of the fourth ventricle: an ominous predictor. J Neurosurg. 1994;80:805–9.
Ozdemir O, Calisaneller T, Hasturk A, Aydemir F, Caner H, Altinors N. Prognostic significance of third ventricle dilation in spontaneous intracerebral hemorrhage: a preliminary clinical study. Neurol Res. 2008; 30(4):406–10.
Findlay JM, Jacka MJ. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery. 2004;55:532–7. (discussion 7–8).
Torres A, Plans G, Martino J, et al. Fibrinolytic therapy in spontaneous intraventricular haemorrhage: efficacy and safety of the treatment. Br J Neurosurg. 2008;22:269–74.
Adams RE, Diringer MN. Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology. 1998;50:519–23.
Mayfrank L, Kissler J, Raoofi R, et al. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment. Stroke. 1997;28:141–8.
Engelhard HH, Andrews CO, Slavin KV, Charbel FT. Current management of intraventricular hemorrhage. Surg Neurol. 2003;60:15–21. (discussion 2).
Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose–effect relationship. J Neurol Sci. 2002;202:35–41.
Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model. Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery. 1986;19:553–72.
Huttner HB, Nagel S, Tognoni E, et al. Intracerebral hemorrhage with severe ventricular involvement: lumbar drainage for communicating hydrocephalus. Stroke. 2007;38:183–7.
Tung MY, Ong PL, Seow WT, Tan KK. A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg. 1998;12:234–9.
Akdemir H, Selcuklu A, Pasaoglu A, Oktem IS, Kavuncu I. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev. 1995;18:95–100.
Coplin WM, Vinas FC, Agris JM, et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke. 1998;29:1573–9.
Gubucz I, Kakuk I, Major O, et al. Effectiveness and safety of intraventricular fibrinolysis in secondary intraventricular hemorrhages (a prospective, randomized study). Orv Hetil. 2004;145:1609–15.
Lee MW, Pang KY, Ho WW, Wong CK. Outcome analysis of intraventricular thrombolytic therapy for intraventricular haemorrhage. Hong Kong Med J. 2003;9:335–40.
Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke. 2000;31:841–7.
Naff NJ, Hanley DF, Keyl PM, et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery. 2004;54:577–83. (discussion 83–4).
Rainov NG, Burkert WL. Urokinase infusion for severe intraventricular haemorrhage. Acta Neurochir (Wien). 1995;134:55–9.
Rajendra T, Kumar K, Liang LH. Hypertensive primary intraventricular hemorrhage due to a phaeochromocytoma. ANZ J Surg. 2006;76:664–7.
Shen PH, Matsuoka Y, Kawajiri K, et al. Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir (Tokyo). 1990;30:329–33.
Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg. 1991;74:81–6.
Tush GM, Tesoro EP, Prabhu S, Brown K, Bullock MR. Intraventricular urokinase for the treatment of intraventricular hemorrhage (abstract). Crit Care Med. 1999;27:A79.
Azmi-Ghadimi H, Heary RF, Farkas JE, Hunt CD. Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for the acute treatment of casted ventricles from cerebral aneurysm hemorrhage: two technical case reports. Neurosurgery. 2002;50:421–4. (discussion 4–5).
Deutsch H, Rodriguez JC, Titton RL. Lower dose intraventricular T-PA fibrinolysis: case report. Surg Neurol. 2004;61:460–3. (discussion 3).
Findlay JM, Grace MG, Weir BK. Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery. 1993;32:941–7. (discussion 7).
Findlay JM, Weir BK, Stollery DE. Lysis of intraventricular hematoma with tissue plasminogen activator. Case report. J Neurosurg. 1991;74:803–7.
Fountas KN, Kapsalaki EZ, Parish DC, et al. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage. South Med J. 2005;98:767–73.
Goh KY, Poon WS. Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage. Surg Neurol. 1998;50:526–31. (discussion 31–2).
Grabb PA. Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: technical case report. Neurosurgery. 1998;43:966–9.
Hall B, Parker D Jr, Carhuapoma JR. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling. Neurocrit Care. 2005;3:153–6.
Ionita CC, Ferrara J, McDonagh DL, Grossi P, Graffagnino C. Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage. Neurocrit Care. 2005;3:246–8.
Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien). 1993;122:32–8.
Mayfrank L, Rohde V, Gilsbach JM. Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations. Br J Neurosurg. 1999;13:128–31.
Prat-Acin R, Galeano-Senabre I, Conde-Garcia FJ, Febles-Garcia P, Gonzalez-Feria L. Fibrinolytic treatment of cerebral intraventricular hemorrhage. Rev Neurol. 2001;33:544–7.
Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry. 1995;58:447–51.
Schwarz S, Schwab S, Steiner HH, Hanley D, Hacke W. Fibrinolysis of intraventricular hematoma with rt-PA. Nervenarzt. 1999;70:123–30.
Slavin KV, Ausman JI, Charbel FT, Andrews C, Misra M, Munoz LF. Results of the treatment of intraventricular hemorrhage with recombinant tissue plasminogen activator in a series of 10 patients (abstract). J Neurosurg. 1998;88:194a.
Varelas PN, Rickert KL, Cusick J, et al. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery. 2005;56:205–13. (discussion 13).
Vereecken KK, Van Havenbergh T, De Beuckelaar W, Parizel PM, Jorens PG. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator: a clinical study of 18 cases. Clin Neurol Neurosurg. 2006;108:451–5.
Huttner HB, Schwab S, Bardutzky J. Lumbar drainage for communicating hydrocephalus after ICH with ventricular hemorrhage. Neurocrit Care. 2006;5:193–6.
Huttner HB, Tognoni E, Bardutzky J, et al. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case–control study. Eur J Neurol. 2008;15:342–9.
Goh KY, Hsiang JN, Zhu XL, Poon WS. Intraventricular recombinant tissue plasminogen activator for treatment of spontaneous intraventricular haemorrhage in pregnancy. J Clin Neurosci. 1999;6:158–9.
Jorens PG, Menovsky TM, Voormolen MH, Van Den Brande E, Parizel PM. Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations. No absolute contraindications as rescue therapy prior to surgical repair or embolisation? Clin Neurol Neurosurg 2009;111(6):544–50.
Staykov D, Huttner HB, Lunkenheimer J, et al. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage. J Neurol Neurosurg Psychiatry. 2010;81:105–8.
Staykov D, Huttner HB, Struffert T, et al. Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke. 2009;40:3275–80.
Hayashi M, Handa Y, Kobayashi H, Kawano H, Nozaki J. Management of intraventricular haemorrhage in patients with haemorrhagic cerebrovascular diseases. Br J Neurosurg. 1988;2:23–32.
Hanley D. Final results CLEARIVH Trial: clot lysis, safety and 30 day functional outcomes. In: European stroke conference, Nice, France, 13–16th May 2008.
Morgan T, Awad I, Keyl P, Lane K, Hanley D. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008;105:217–20.
Huttner HB, Kohrmann M, Berger C, Georgiadis D, Schwab S. Influence of intraventricular hemorrhage and occlusive hydrocephalus on the long-term outcome of treated patients with basal ganglia hemorrhage: a case–control study. J Neurosurg. 2006;105:412–7.
Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51:170–81. (discussion 81–2).
Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol. 2000;247:117–21.
Hayashi M, Handa Y, Kobayashi H, Kawano H, Nozaki J, Hirose S. Prognosis of intraventricular hemorrhage due to hypertensive hemorrhagic cerebrovascular disease. Zentralbl Neurochir. 1988;49:101–8.
Mayr U, Bauer P, Fischer J. Non-traumatic intracerebral haemorrhage. Prognostic implications of neurological and computer-tomographical findings in 100 consecutive patients. Neurochirurgia. 1983;26:36–41.
Pia HW. Spontaneous intracerebral hematomas. Advances in diagnosis and therapy. Berlin, Heidelberg, New York: Springer; 1980.
Matsumoto K, Hondo H. CT-guided stereotaxic evacuation of hypertensive intracerebral hematomas. J Neurosurg. 1984;61:440–8.
Ikeda Y, Nakazawa S, Higuchi H, Ueda K, Yajima K. Clinical aspects and prognosis of intraventricular hemorrhage with cerebrovascular disease. CT findings and etiological analysis. Neurol Med Chir (Tokyo). 1982;22:822–8.
Lu B. Hypertensive putaminal hemorrhage with intraventricular hemorrhage–50 clinical cases and 6 pathoanatomy cases. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1989;22:328–30, 381.
Ruscalleda J, Peiro A. Prognostic factors in intraparenchymatous hematoma with ventricular hemorrhage. Neuroradiology. 1986;28:34–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Staykov, D., Bardutzky, J., Huttner, H.B. et al. Intraventricular Fibrinolysis for Intracerebral Hemorrhage with Severe Ventricular Involvement. Neurocrit Care 15, 194–209 (2011). https://doi.org/10.1007/s12028-010-9390-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-010-9390-x